Film and digital imaging vendor Sterling Diagnostic Imaging willshowcase its latest work in Direct Radiography, a work-in-progresstechnology for direct conversion of x-rays into digital data.Sterling debuted DR at the RSNA meeting last year in the
Film and digital imaging vendor Sterling Diagnostic Imaging willshowcase its latest work in Direct Radiography, a work-in-progresstechnology for direct conversion of x-rays into digital data.Sterling debuted DR at the RSNA meeting last year in the company'sprevious incarnation as Du Pont's Medical Products group (SCAN12/13/95).
Since then, Sterling, of Glasgow, DE, has worked on expandingthe size of the DR detector to 14 x 17 inches, according to DeborahDuBois, senior vice president and business manager of the DR program.Sterling will demonstrate a 14 x 17 version of DR, and is stilltargeting a commercial release date of 1998 for DR products, DuBoissaid.
Other news at Sterling's booth is the company's major investmentin new printing technology. Sterling in October announced a dealwith Polaroid in which Sterling would buy the assets of Polaroid'sHelios dry-process laser imaging technology (SCAN 11/6/96). Sterlingwill take over manufacturing and marketing of Helios printers,although Polaroid will continue to manufacture Helios film. Sterlingplans to begin selling Helios by January.
In addition to Helios, Sterling last month released detailson its work developing a new non-laser dry printer with Tektronix(SCAN 11/20/96). The as-yet unnamed printer is based on ink-jettechnology developed by Tektronix and adapted for the medicalimaging market by Sterling. Shipments of that product, which willoccupy a lower price point than Helios, are expected in the thirdquarter of 1997.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.